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Deciding what to eat
C
ells adapt to their surroundings by 
generating new organelles when 
needed and degrading them when 
they become damaged or superfl  uous. Many 
organelles, including the ER and mitochon-
dria, are turned over by autophagy—the 
“self-eating” pathway in which cytoplasmic 
contents are engulfed in a double-mem-
braned vesicle and transported to the lyso-
some to be broken down and recycled. But, 
just like people, cells have to watch what 
they eat and ensure only the right organelles 
are degraded. Manjithaya et al. now reveal 
the signaling pathway that specifi  cally stim-
ulates the destruction of peroxisomes (1).
Because peroxisomes contain the en-
zymes necessary for catabolizing fatty acids, 
yeast grown on oleate produce extra peroxi-
somes to exploit this carbon source. But 
switching the yeast to glucose-containing 
medium renders these peroxisomes redun-
dant. In a process called pexophagy, cells 
dismantle their excess peroxisomes using 
their autophagic machinery (2). “But how 
do you take a nonselective process like au-
tophagy and make it only eat peroxi-
somes?” asks Suresh Subramani, from the 
University of California, San Diego.
Subramani and colleagues have identi-
fied factors that control the selective 
destruction of peroxisomes, including a 
protein called Atg30 that targets the organ-
elles to the autophagy pathway (3). Little 
is known about the signaling events that 
control pexophagy, how-
ever, so Manjithaya et al. 
screened for yeast kinase 
mutants that couldn’t elimi-
nate their peroxisomes after 
switching from oleate to 
glucose media (1). The re-
searchers discovered that 
the mitogen-activated protein kinase 
(MAPK) Slt2p was essential for peroxi-
some turnover. “Our assay was pexophagy-
specifi  c but we were concerned that this 
might be a general signaling pathway for 
all autophagic processes,” says Subramani. 
“We were really excited to fi  nd that Slt2p 
didn’t affect general autophagy or the se-
lective removal of other organelles.”
Slt2p is at the bottom of a signaling cas-
cade activated by damage to the yeast cell 
wall (4). All of the upstream kinases in the 
pathway were also required for pexophagy, 
as was Mid2p—a cell surface protein that 
senses cell wall integrity and initiates sig-
naling to Slt2p. But what does the cell wall 
have to do with peroxisome turnover?
In fact, activating the MAPK path-
way wasn’t sufficient to induce pex-
ophagy. The team thinks that simultane-
ous activation of protein kinase A (PKA) 
by the entry of hexoses, such as glucose, 
into yeast cells is also re-
quired for peroxisome re-
moval. The presence of glu-
cose stimulates PKA by 
up-regulating  cAMP levels 
and, Subramani speculates, 
activates Mid2p by inducing 
changes in the glycosylation 
pattern of cell wall proteins. The coinci-
dence of these two signals causes cells to 
destroy their peroxisomes. “You don’t 
want to trigger pexophagy by mistake,” 
Subramani explains, “so you need signal-
ing through both of these pathways.”
How does Slt2p promote pexophagy? 
Manjithaya et al. found that peroxisomes 
were still engulfed into double-membraned 
“pexophagosomes” in cells lacking Slt2p, 
suggesting that this MAPK controls a later 
step in the pathway, such as transport to, or 
fusion with, the vacuole (the yeast equiva-
lent of lysosomes). Although MAPKs of-
ten target transcription factors, Subramani 
thinks that Slt2p regulates pexophagy more 
directly by phosphorylating a protein on 
the pexophagosome surface. “That makes 
our task more diffi  cult as it’s likely to be a 
novel substrate,” he adds. “But at least we 
know where to start looking.”
Subramani is also interested in how the 
MAPK and hexose-sensing pathways are 
integrated, and to what extent this regula-
tion is conserved across evolution. He sus-
pects that the process may ultimately be 
linked to human disease—defects in both 
peroxisome biogenesis and autophagy 
contribute to a variety of disorders. “These 
are important proteins,” Subramani says. 
“As we start to look at selective organelle 
turnover, there will be disease connections 
that we’ll need to explore.”
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(Clockwise from top left) Ravi Manjithaya, Suresh Subramani, Shveta Jain, and Jean-Claude 
Farré identify a yeast MAP kinase cascade that, together with hexose sugars, induces cells to 
degrade their peroxisomes via a selective form of autophagy. Cells grown on oleate (top left) 
produce peroxisomes (green) to metabolize the fatty acid, but these organelles are superﬂ  uous 
in the presence of glucose (top right) and so are targeted to the vacuole (red) for destruction. 
Yeast lacking the MAP kinase Slt2p still form peroxisomes on oleate (bottom left) but can’t 
degrade them in response to glucose (bottom right).
“You don’t 
want to trigger 
pexophagy 
by mistake.”
A signaling pathway directs cells to degrade peroxisomes while leaving other organelles untouched.
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